Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04014348 · ClinicalTrials.gov registry record

Geospatial Analysis of Neighborhood Environmental Stress in Relation to Biological Markers of Cardiovascular Health and Health Behaviors in Women

A clinical trial of Cardiovascular (CV) Risk, sponsored by National Heart, Lung, and Blood Institute (NHLBI).

Recruiting
Registry status
250
Enrollment target
1
Study location

NCT04014348: Recruiting study of Cardiovascular (CV) Risk, sponsored by National Heart, Lung, and Blood Institute (NHLBI).

NCT04014348 is a study of Cardiovascular (CV) Risk that is actively recruiting participants, run by National Heart, Lung, and Blood Institute (NHLBI). The registered enrollment target is 250 participants, above the 78-participant average among 4 other Cardiovascular (CV) Risk trials with a reported enrollment target (221% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04014348, a study of Cardiovascular (CV) Risk, is actively recruiting participants, sponsored by National Heart, Lung, and Blood Institute (NHLBI).

RECRUITING
Registry status
250 participants
Enrollment target
1
Study location

Study Summary

Background: Heart disease is a leading cause of death in the United States. Healthy diet and exercise improve heart health. Some features of where a person lives can lead to stress and decrease chances for exercise. Researchers want to see how these factors may increase the risk of heart disease in women. Objective: To see if there are differences in stress levels between women who live in different parts of Washington, DC. Also, to see how these women use their neighborhoods for exercise. Eligibility: Healthy white or black females ages 19-45 who live in Washington, DC, who have access to a smartphone Design: Participants may stay at the NIH Clinical Center overnight for a 2-day visit. Visit 1 will include: Physical exam Blood tests Electrocardiogram: Electrodes on the participant s skin will measure heart activity. PET/CT scan: Participants will get an injection. They will lie in a machine that takes pictures of the body. Surveys Body size measurements Nutrition consultation Blood vessel tests: This is measured with blood pressure cuffs, a device placed on the participant s fingertip, and a probe placed on the participant s neck. Resting Energy Expenditure: Participants will breathe under a clear hood for 45 minutes. Participants will be followed for about 2 weeks. They will wear a device on the wrist and carry a GPS device. Through a mobile app, they will answer short daily surveys on stress and exercise. Visit 2- Device return Nutritional consultation

Primary Outcome

Stress-related neural activity will be estimated by neuroimaging (18-FDG PET/CT amygdala activity)

Conditions Studied

Study Locations (1)

Maryland

  • National Institutes of Health Clinical Center - Bethesda

Trial Details

FieldValue
Enrollment Target 250 participants
Start Date 2021-10-20
Est. Completion 2026-12-26

What NCT04014348 shows while recruiting

NCT04014348 is an observational study that tracks outcomes without assigning an intervention. The registered 250 participants enrollment target is mid-sized for trials with a published cap, above the 78-participant average among 4 other Cardiovascular (CV) Risk trials with a reported enrollment target (221% higher).

The record links to 1 condition, with Cardiovascular (CV) Risk appearing as the primary indexed condition, and to 0 interventions.

NCT04014348 reports a single indexed study location in Maryland.

Frequently Asked Questions

What is clinical trial NCT04014348 about?

NCT04014348 is a clinical study titled "Geospatial Analysis of Neighborhood Environmental Stress in Relation to Biological Markers of Cardiovascular Health and Health Behaviors in Women". Background: Heart disease is a leading cause of death in the United States. Healthy diet and exercise improve heart health. Some features of where a person lives can lead to stress and decrease chances for exercise. Researchers want to see how these factors may increase the risk of heart disease in...

What is the current status of trial NCT04014348?

This trial is currently recruiting. The enrollment target is 250 participants. The study started on 2021-10-20. Estimated completion is 2026-12-26.

What conditions does trial NCT04014348 study?

This clinical trial studies the following conditions: Cardiovascular (CV) Risk.

Who is sponsoring clinical trial NCT04014348?

This trial is sponsored by National Heart, Lung, and Blood Institute (NHLBI), which has 501 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04014348 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cardiovascular (CV) Risk

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00483249 · 250 participants · NA

    Endovascular Exclusion of Thoracoabdominal and/or Paravisceral Abdominal Aortic Aneurysm

  • NCT00777712 · 250 participants

    Mechanisms Underlying Impaired Diabetic Wound Healing

  • NCT01451502 · 250 participants · NA

    Infusion of Cell Populations From Unlicensed Umbilical Cord Blood Units

  • NCT01771718 · 250 participants

    Pilot Study on In-vivo Non-invasive Skin Imaging Using Multiphoton Microscopy

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04014348, the US trial registry maintained by the National Library of Medicine. NCT04014348 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.